Search bioRxiv⌕ Search

Biology subjects

Kiaei, A. A.

Publications and source records attributed to Kiaei, A. A..

2 recordsLinked to original sources

Emerging Drug Combinations for Targeting Tongue Neoplasms Associated Proteins/Genes: Employing Graph Neural Networks within the RAIN Protocol

BackgroundTongue Neoplasms is a common form of malignancy, with squamous cell carcinoma of the tongue being the most frequently diagnosed type due to regular mechanical stimulation. Its prevalence remains on the rise among neoplastic cancer cases. Finding effective combinations of drugs to target the genetic and protein elements contributing to the development of Managing Tongue Neoplasms poses a difficulty owing to the intricate and varied nature of the ailment. MethodIn this research, we introduce a novel approach using Deep Modularity Networks (DMoN) to identify potential synergistic drug combinations for the condition, following the RAIN protocol. This procedure comprises three primary phases: First, employing Graph Neural Network (GNN) to propose drug combinations for treating the ailment by extracting embedding vectors of drugs and proteins from an extensive knowledge graph containing various biomedical data types, such as drug-protein interactions, gene expression, and drug-target interactions. Second, utilizing natural language processing to gather pertinent articles from clinical trials involving the previously recommended drugs. Finally, conducting network meta-analysis to evaluate the comparative efficacy of these drug combinations. ResultWe utilized our approach on a dataset containing drugs and genes as nodes, connected by edges indicating their associated p-values. Our DMoN model identified Cisplatin, Bleomycin, and Fluorouracil as the optimal drug combination for targeting the human genes/proteins associated with this cancer. Subsequent scrutiny of clinical trials and literature confirmed the validity of our findings. Additionally, network meta-analysis substantiated the efficacy of these medications concerning the pertinent genes. ConclusionThrough the utilization of DMoN as part of the RAIN protocol, our method introduces a fresh and effective way to suggest notable drug combinations for addressing proteins/genes linked to Tongue Neoplasms. This approach holds promise in assisting healthcare practitioners and researchers in pinpointing the best treatments for patients, as well as uncovering the fundamental mechanisms of the disease. HighlightsO_LIA new method using Deep Modularity Networks and the RAIN protocol can find the best drug combinations for treating Tongue Neoplasms, a common and deadly form of cancer. C_LIO_LIThe method uses a Graph Neural Network to suggest drug pairings from a large knowledge graph of biomedical data, then searches for clinical trials and performs network meta-analysis to compare their effectiveness. C_LIO_LIThe method discovered that Cisplatin, Bleomycin, and Fluorouracil are suitable drugs for targeting the genes/proteins involved in this cancer, and confirmed this finding with literature review and statistical analysis. C_LIO_LIThe method offers a novel and powerful way to assist doctors and researchers in finding the optimal treatments for patients with Tongue Neoplasms, and to understand the underlying causes of the disease. C_LI O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=108 SRC="FIGDIR/small/598402v1_ufig1.gif" ALT="Figure 1"> View larger version (44K): org.highwire.dtl.DTLVardef@56bc74org.highwire.dtl.DTLVardef@6e9308org.highwire.dtl.DTLVardef@177144aorg.highwire.dtl.DTLVardef@d53c5e_HPS_FORMAT_FIGEXP M_FIG C_FIG

cancer biology↗

AI-Enhanced RAIN Protocol: A Systematic Approach to Optimize Drug Combinations for Rectal Neoplasm Treatment

BackgroundRectal cancers, or rectal neoplasms, are tumors that develop from the lining of the rectum, the concluding part of the large intestine ending at the anus. These tumors often start as benign polyps and may evolve into malignancies over several years. The causes of rectal cancer are diverse, with genetic mutations being a key factor. These mutations lead to uncontrolled cell growth, resulting in tumors that can spread and damage healthy tissue. Age, genetic predisposition, diet, and hereditary conditions are among the risk factors. Treating rectal cancer is critical to prevent severe health issues and death. Untreated, it can cause intestinal blockage, metastasis, and deteriorate the patients quality of life. Effective treatment hinges on finding the right drug combinations to improve therapeutic outcomes. Given the intricacies of cancer biology, treatments often combine surgery, chemotherapy, and radiation, with drugs chosen to target different tumor growth mechanisms, aiming to reduce the tumor and limit side effects. The continuous advancement in cancer treatments highlights the need for ongoing research to discover new drug combinations, offering patients improved recovery prospects and a better quality of life. This background encapsulates a detailed yet succinct understanding of rectal neoplasms, their origins, the urgency of treatment, and the quest for effective drug therapies, paving the way for discussions on treatment advancements and patient care impacts. MethodThis study employed the RAIN protocol, comprising three steps: firstly, utilizing the GraphSAGE model to propose drug combinations for rectal neoplasm treatment Each node in the graph model is a drug or a human gene/protein that acts as potential target for the disease, and the edges are P-values between them; secondly, conducting a systematic review across various databases including Web of Science, Google Scholar, Scopus, Science Direct, PubMed, and Embase, with NLP investigation; and thirdly, employing a meta-analysis network to assess the efficacy of drugs and genes in relation to each other. All implementations was conducted using Python software. ResultThe study evaluated the efficacy of Oxaliplatin, Leucovorin, and Capecitabine in treating Rectal Neoplasms, confirming their effectiveness through a review of 30 studies. The p-values for individual drugs were 0.019, 0.019, and 0.016 respectively, while the combined use of all three yielded a p-value of 0.016. ConclusionGiven the significance of rectal neoplasms, policymakers are urged to prioritize the healthcare needs of affected individuals. Utilizing artificial intelligence within the RAIN protocol can offer valuable insights for tailoring effective drug combinations to better address the treatment and management of rectal neoplasms patients. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=90 SRC="FIGDIR/small/596215v1_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@1967f95org.highwire.dtl.DTLVardef@1921c52org.highwire.dtl.DTLVardef@181809dorg.highwire.dtl.DTLVardef@122d8b4_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIRectal cancers, evolving from benign polyps to malignancies, underscore the critical need for timely and effective treatment to prevent severe health complications. C_LIO_LIGenetic mutations, a pivotal factor in rectal cancer, trigger uncontrolled cell growth and necessitate targeted drug therapies to combat tumor spread. C_LIO_LIThe RAIN protocol, leveraging the GraphSAGE model and systematic reviews, offers a novel approach to identify potent drug combinations for rectal neoplasm treatment. C_LIO_LIThe studys findings advocate for policy intervention to ensure that healthcare systems adequately support individuals battling rectal neoplasms, with AI-driven protocols enhancing patient care. C_LI

bioinformatics↗